Versant Ventures related stories
All articles and analysis
Corporate Wellness Delivers Health and Fitness ROIWith the promise of large potential exits from insurance providers, more entrepreneurs and investors are looking at corporate fitness startups
Ceterix Orthopaedics Seals $19.5MCeterix Orthopaedics Inc., a developer of surgical tools for arthroscopic procedures, has raised $19.5 million in Series B financing. New investor Novo Ventures led the round. Previous investors Versant Ventures and 5AM Ventures also participated. Peter Bisgaard, Partner with Novo Ventures, joined the Board of Ceterix.
- Lone Star-backed Del Frisco’s pulls $100m IPO
The steakhouse operator, acquired as part of the $600m take-private of Lone Star Steakhouse & Saloon in 2006, cited ‘current public market conditions’ in its filing with the SEC.
- Versant raises $500m for Fund IV
The California-based firm, which invests in seed and early stage healthcare companies, has brought its capital under management to a total of $1.6bn with the closure of its fourth fund after two months in the market.
- Deal round-up
Mowbray launches European venture FoF; Apatech raises £6.5 million in Series B financing; KKR leads $250m pharma round; ARCH Venture closes $350m Fund VI;
- KKR leads $250m pharma round
Jazz Pharmaceuticals snags one of the largest second round financings on record for a speciality pharma company without any commercialized drugs.
- Deal round-up 29/10/03
European investors back US nanotech round; Apax leads Wisair round; ePlanet Ventures invests in End2End; Bumper round for Biospect
- Deal round up 05/11/02
DrKC increases Euromedic investment; Sofinnova invests in US biopharma round; ICC backs 2PM Technologies second round
- Venture capital funds raised $55bn in 2001
200 new funds were launched in the year, 23 of which were dedicated to investment in the life science sector.
- Flexion Therapeutics Adds $20M
Woburn, Mass.-based Flexion Therapeutics Inc. has closed on $20 million in Series B financing. Novo Ventures, a new investor, led the round. Flexion's existing investors 5AM Ventures, Pfizer Venture Investments, Sofinnova Partners and Versant Ventures also participated. Proceeds will be used to fund late stage clinical development of the company's therapies for the treatment of osteoarthritis. Heath Lukatch, a partner in Novo Ventures, has joined the company's board.